BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, June 12, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Money raised by biopharma

June 12, 2026
Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.
Read More

Regulatory actions for June 12, 2026

June 12, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Camurus, Guardant, Karl Storz, Pharmaessentia, Roche, Wave.
Read More

Other news to note for June 12, 2026

June 12, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Amgen, Biontech, Chemocentryx, Chiesi, Emalex, Forus, Kalvista, Moderna, Pharmaessentia, Pfizer, Precision, Sanofi, Snke, Teva, Veraxa.
Read More

In the clinic for June 12, 2026

June 12, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron, Enliven, Glyconex, Humacyte, Imviva, Johnson & Johnson, Kura, Novartis, Nurix, Oryzon, Renovorx, Silence, Syndax, Takeda, Theriva, Vertex.
Read More

Financings for June 12, 2026

June 12, 2026
Biopharma and med-tech companies raising money in public or private financings, including: Atossa, Cequr, Edesa, Humacyte, Ideaya, Kardigan, Nyxoah, Thruflo.
Read More

Appointments and advancements for June 12, 2026

June 12, 2026
New hires and promotions in the biopharma and med-tech industries, including: Ambros, Aspen, Bighat, Dentsply, Fedora, Harbour, Oriva, Palisade, Phoremost, Poxel, Relmada, Viking, Vir.
Read More

Today's news in brief

June 12, 2026
BioWorld briefs for June 12, 2026.
Read More

Regulatory actions for June 11, 2026

June 11, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Cellectis, Dermasensor, Eli Lilly, Italfarmaco, Onkos, Organon, Radiomedix, Sibel, Subtle, Takeda, Tris, Vara.
Read More

Other news to note for June 11, 2026

June 11, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Alnylam, Cordex, Cosylab, Excellthera, Genesis, Heron, Medexus, Predicta, Sensorion, Tenacia, Verge.
Read More

In the clinic for June 11, 2026

June 11, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Cullinan, Lophora, Molecular, Nexalin, Sanofi, SPR.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 1808 1809 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • 3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

    Skape Bio unlocks GPCR targets with de novo-designed miniproteins

    BioWorld
    Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
  • New 5-HT2C receptor agonists reported in Hansoh patent

    BioWorld Science
    Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
  • Blood sample tubes after centrifuge

    Pre-disease plasma signature may help redefine lung cancer risk

    BioWorld
    Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing